Correlation Between Denali Therapeutics and Cidara Therapeutics

Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Denali Therapeutics and Cidara Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Cidara Therapeutics.

Diversification Opportunities for Denali Therapeutics and Cidara Therapeutics

-0.23

Correlation Coefficient

Denali Therapeutics  Cidara Therapeutics

Very good diversification

The 3 months correlation between Denali and Cidara is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Cidara Therapeutics go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Cidara Therapeutics

Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Cidara Therapeutics. In addition to that, Denali Therapeutics is 1.0 times more volatile than Cidara Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Cidara Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest  2,525  in Cidara Therapeutics on December 28, 2024 and sell it today you would lose (367.00) from holding Cidara Therapeutics or give up 14.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Denali Therapeutics  vs.  Cidara Therapeutics

Denali Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Cidara Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cidara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Denali Therapeutics and Cidara Therapeutics

The main advantage of trading using opposite Denali Therapeutics and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.

The idea behind Denali Therapeutics and Cidara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.